Cobo M, De Castro J, Isla D, Lozano V, Oyagüez I, Castro-Gomez AJ
Cost-effectiveness of erlotinib as first-line maintenance therapy for advanced non-small-cell lung carcinoma in patients EGFR WT and stable disease after four cycles of chemotherapy
15th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Berlin, Germany. 3-7 nov 2012
Cobo M, De Castro J, Isla D, Lozano V, Oyagüez I, Castro-Gomez AJ